(Q41064375)

26 September 2017

1 reference

title

Head and neck cancer: guidelines for chemotherapy (English)

1 reference

26 September 2017

1 reference

1 reference

head and neck carcinoma

1 reference

G Catimel

1

1 reference

26 September 2017

publication date

1 January 1996

1 reference

26 September 2017

1 reference

26 September 2017

volume

51

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

73-88

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199651010-00006

26 September 2017

exact match

0 references

cites work

A phase II study of Adriamycin in previously untreated squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Overview of combined modality therapies for head and neck cancer

1 reference

12 December 2020

Utility of individualized carboplatin dosing alone and in combination regimens

1 reference

12 December 2020

Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer

1 reference

12 December 2020

Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study

1 reference

12 December 2020

Adjuvant Treatment of Tongue and Floor of the Mouth Cancers

1 reference

12 December 2020

Combined bleomycin and radiotherapy in oral cancer

1 reference

12 December 2020

Evidence-based recommendations against neoadjuvant chemotherapy for routine management of patients with squamous cell head and neck cancer

1 reference

12 December 2020

The chemotherapy of advanced squamous cell carcinomas: Long term results obtained with a combination of methotrexate, the vinca alkaloids and bleomycin

1 reference

12 December 2020

A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer

1 reference

12 December 2020

Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy

1 reference

12 December 2020

A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer

1 reference

12 December 2020

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

12 December 2020

Randomised EORTC Head and Neck Cooperative Group trial of preoperative intra-arterial chemotherapy in oral cavity and oropharynx carcinoma

1 reference

12 December 2020

Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

1 reference

12 December 2020

Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

CLINICAL EXPERIENCE WITH VINBLASTINE SULFATE (NSC-49842) IN SQUAMOUS CELL CARCINOMA AND OTHER MALIGNANCIES

1 reference

12 December 2020

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer

1 reference

12 December 2020

Treatment of carcinoma of the head and neck with intravenous methotrexate.

1 reference

12 December 2020

Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil

1 reference

12 December 2020

Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

24-hour infusion of cis-platinum in head and neck cancers

1 reference

12 December 2020

Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate

1 reference

12 December 2020

Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation

1 reference

12 December 2020

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

1 reference

12 December 2020

Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial

1 reference

12 December 2020

Adjuvant methotrexate-5-fluorouracil for extracapsular squamous cell carcinoma in cervical metastasis

1 reference

12 December 2020

Combined modality therapy of head and neck cancer.

1 reference

12 December 2020

Results in fifty cases of advanced squamous cell carcinoma of the head and neck treated by intravenous chemotherapy

1 reference

12 December 2020

Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer

1 reference

12 December 2020

Improved Results in Combination Chemotherapy of Head and Neck Cancer Using a Kinetically-based Approach: A Randomised Study With and Without Adriamycin

1 reference

12 December 2020

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy

1 reference

12 December 2020

Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM)

1 reference

12 December 2020

Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials

1 reference

12 December 2020

A phase III randomised trial of cistplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group

1 reference

12 December 2020

Failure of short-course multiple drug chemotherapy to benefit patients with recurrent or metastatic head and neck cancer

1 reference

12 December 2020

A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer

1 reference

12 December 2020

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

12 December 2020

Phase II study of carboplatin in head and neck cancer

1 reference

12 December 2020

cis-Dichlorodiamminepltinum(II) in adult patients: Southwest Oncology Group Studies

1 reference

12 December 2020

Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program

1 reference

12 December 2020

Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034

1 reference

12 December 2020

Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam cooperative head and neck cancer study group

1 reference

12 December 2020

Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study

1 reference

12 December 2020

A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck

1 reference

12 December 2020

Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group Study

1 reference

12 December 2020

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group

1 reference

12 December 2020

A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasms

1 reference

12 December 2020

A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers

1 reference

12 December 2020

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

1 reference

12 December 2020

Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

High-dose methotrexate and cis-platinum in the treatment of recurrent head and neck cancer

1 reference

12 December 2020

1 reference

12 December 2020

Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer

1 reference

12 December 2020

Use of methotrexate and 5-FU for recurrent head and neck cancer

1 reference

12 December 2020

Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck

1 reference

12 December 2020

A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.

1 reference

12 December 2020

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

12 December 2020

A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer

1 reference

12 December 2020

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial

1 reference

12 December 2020

Phase II trial of ifosfamide in recurrent and metastatic head and neck cancer

1 reference

12 December 2020

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

12 December 2020

Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck. A Southeastern Cancer Study Group trial.

1 reference

12 December 2020

Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer

1 reference

12 December 2020

Advanced recurrent squamous cell carcinoma of the head and neck. Results of a chemotherapeutic regimen with adriamycin, bleomycin, 5-fluorouracil, methotrexate, and vitamin A

1 reference

12 December 2020

Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis-diamminedichloroplatinum II in an effective outpatient schedule

1 reference

12 December 2020

Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo

1 reference

12 December 2020

Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck

1 reference

12 December 2020

The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancer

1 reference

12 December 2020

Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial

1 reference

12 December 2020

Chemotherapy of head and neck cancer: Combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin

1 reference

12 December 2020

Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

1 reference

12 December 2020

cis-Dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer

1 reference

12 December 2020

High-dose versus low-dose cisplatin in advanced head and neck squamous carcinoma: a randomized study

1 reference

12 December 2020

Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program

1 reference

12 December 2020

A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck

1 reference

12 December 2020

Cis-platinum therapy of previously treated head and neck cancer: the Southwest Oncology Group's two-dose-per-month outpatient regimen

1 reference

12 December 2020

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer

1 reference

12 December 2020

Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study.

1 reference

12 December 2020

Factors that affect response to chemotherapy and survival of patients with advanced head and neck cancer

1 reference

12 December 2020

Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer

1 reference

12 December 2020

Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial

1 reference

12 December 2020

10.2165/00003495-199651010-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

26 September 2017

1015126933

0 references

Fatcat ID

release_duh7xyy4azgu3ixrso4ku2ipuy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/duh7xyy4azgu3ixrso4ku2ipuy

24 November 2022

mapped directly with Wikidata item

1 reference